A detailed history of Bank Of Montreal transactions in Repligen Corp stock. As of the latest transaction made, Bank Of Montreal holds 36,752 shares of RGEN stock, worth $5.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,752
Previous 35,177 4.48%
Holding current value
$5.29 Million
Previous $6.47 Million 28.4%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$120.0 - $182.95 $189,000 - $288,146
1,575 Added 4.48%
36,752 $4.63 Million
Q1 2024

May 13, 2024

SELL
$170.78 - $208.42 $1.39 Million - $1.7 Million
-8,136 Reduced 18.78%
35,177 $6.47 Million
Q4 2023

Feb 08, 2024

SELL
$114.17 - $185.35 $380,642 - $617,956
-3,334 Reduced 7.15%
43,313 $7.79 Million
Q3 2023

Nov 01, 2023

SELL
$138.78 - $176.51 $17.9 Million - $22.7 Million
-128,695 Reduced 73.4%
46,647 $7.42 Million
Q2 2023

Aug 02, 2023

BUY
$138.42 - $180.31 $20.4 Million - $26.6 Million
147,356 Added 526.53%
175,342 $24.8 Million
Q1 2023

Jun 13, 2024

BUY
$154.26 - $198.1 $30.1 Million - $38.7 Million
195,328 Added 555.27%
230,505 $38.8 Million
Q4 2022

Feb 01, 2023

BUY
$162.42 - $220.56 $398,091 - $540,592
2,451 Added 9.6%
27,986 $4.74 Million
Q3 2022

Nov 10, 2022

SELL
$160.42 - $256.21 $1.72 Million - $2.74 Million
-10,695 Reduced 29.52%
25,535 $5.56 Million
Q2 2022

Aug 11, 2022

SELL
$140.68 - $188.02 $69,636 - $93,069
-495 Reduced 1.35%
36,230 $6.08 Million
Q1 2022

May 12, 2022

BUY
$161.19 - $257.96 $1.32 Million - $2.12 Million
8,202 Added 28.76%
36,725 $6.93 Million
Q4 2021

Feb 11, 2022

SELL
$247.59 - $304.47 $2.9 Million - $3.57 Million
-11,728 Reduced 29.14%
28,523 $7.46 Million
Q3 2021

Nov 12, 2021

SELL
$194.77 - $324.21 $2.94 Million - $4.89 Million
-15,081 Reduced 27.26%
40,251 $11.5 Million
Q2 2021

Aug 12, 2021

BUY
$165.87 - $220.95 $9.18 Million - $12.2 Million
55,332 New
55,332 $11.3 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.98B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.